Top compounds associated with response to GFM1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.6
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA Bosutinib FIMM pan-cancer AAC 0.16 0.6
mRNA GDC-0449 FIMM pan-cancer AAC -0.081 0.6
mRNA Crizotinib FIMM pan-cancer AAC -0.082 0.7
mRNA A-804598 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.026 0.7
mRNA Irinotecan gCSI pan-cancer AAC -0.024 0.7
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA PD-0325901 CCLE pan-cancer AAC -0.019 0.7
Download CSV